N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity.

Taccone-Gallucci, M; Manca-di-Villahermosa, S; Battistini, L; Stuffler, R G; Tedesco, M; Maccarrone, M

Taccone-Gallucci, M; Manca-di-Villahermosa, S; Battistini, L; Stuffler, R G; Tedesco, M; Maccarrone, M.

Affiliation

Taccone-Gallucci M; Section of Nephrology, Department of Biopathology and Imaging Techniques, Tor Vergata University, Rome, Italy. mmaccarrone@unite.it

Kidney Int ; 69(8): 1450-4, 2006 Apr.

Article in En | MEDLINE | ID: mdl-16531984

Subject(s)

Fatty Acids, Omega-3/therapeutic use; Kidney Failure, Chronic/drug therapy; Lipoxygenase Inhibitors; Oxidative Stress/drug effects; Renal Dialysis; Aged; Apoptosis; Arachidonate 5-Lipoxygenase/genetics; Arachidonate 5-Lipoxygenase/metabolism; Case-Control Studies; Gene Expression; Humans; Kidney Failure, Chronic/metabolism; Leukocytes, Mononuclear/drug effects; Leukocytes, Mononuclear/enzymology; Leukotriene B4/analysis; Lipid Peroxidation/drug effects; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Fatty Acids, Omega-3 / Renal Dialysis / Lipoxygenase Inhibitors / Oxidative Stress / Kidney Failure, Chronic Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Kidney Int Year: 2006 Type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links